No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
BIVI BioVie
- 1.900
- -0.180-8.65%
Close Dec 20 16:00 ET
- 1.940
- +0.040+2.11%
Post 20:01 ET
33.76MMarket Cap-0.37P/E (TTM)
2.127High1.900Low1.47MVolume2.050Open2.080Pre Close2.92MTurnover10.40%Turnover RatioLossP/E (Static)17.77MShares33.10052wk High2.40P/B26.78MFloat Cap1.04052wk Low--Dividend TTM14.10MShs Float460.977Historical High--Div YieldTTM10.93%Amplitude1.040Historical Low1.991Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
BioVie Files to Sell 7.71M Shares of Common Stock for Holders
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
BioVie | 10-Q: Q1 2025 Earnings Report
Express News | BioVie Inc - Pd-202 Trial Expected to Start Early 2025, Results by Late 2025
Express News | Biovie’s Upcoming Parkinson’s Disease Clinical Trial Is Fully Funded
(BIVI) - Analyzing BioVie's Short Interest
Heat List
US
Overall
Symbol
Price
% Chg
No Data